273 related articles for article (PubMed ID: 31545467)
1. Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
Jiang X; Shen TY; Lu H; Shi C; Liu Z; Qin H; Wang F
Oncol Rep; 2019 Nov; 42(5):2117-2129. PubMed ID: 31545467
[TBL] [Abstract][Full Text] [Related]
2. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.
Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL
Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067
[TBL] [Abstract][Full Text] [Related]
3. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties.
Kong X; Chen J; Xie W; Brown SM; Cai Y; Wu K; Fan D; Nie Y; Yegnasubramanian S; Tiedemann RL; Tao Y; Chiu Yen RW; Topper MJ; Zahnow CA; Easwaran H; Rothbart SB; Xia L; Baylin SB
Cancer Cell; 2019 Apr; 35(4):633-648.e7. PubMed ID: 30956060
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
[TBL] [Abstract][Full Text] [Related]
5. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
[TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
[TBL] [Abstract][Full Text] [Related]
8. Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell proliferation and apoptosis.
Zhu M; Xu Y; Ge M; Gui Z; Yan F
Cancer Sci; 2015 Jul; 106(7):833-9. PubMed ID: 25940709
[TBL] [Abstract][Full Text] [Related]
9. DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter.
Shao K; Pu W; Zhang J; Guo S; Qian F; Glurich I; Jin Q; Ma Y; Ju S; Zhang Z; Ding W
Clin Epigenetics; 2021 Apr; 13(1):89. PubMed ID: 33892791
[TBL] [Abstract][Full Text] [Related]
10. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
11. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
13. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
[TBL] [Abstract][Full Text] [Related]
14. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
Ye WC; Gao L; Huang J; Fang XM; Xie G
Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3.
Liu T; Han Z; Li H; Zhu Y; Sun Z; Zhu A
Mol Cancer; 2018 Aug; 17(1):118. PubMed ID: 30098595
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer.
Liu RT; Wang GR; Liu C; Qiu J; Yan LK; Li XJ; Wang XQ
Int J Mol Med; 2016 Sep; 38(3):703-12. PubMed ID: 27430286
[TBL] [Abstract][Full Text] [Related]
18. MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.
Lin Y; Chen Z; Lin S; Zheng Y; Liu Y; Gao J; Chen S
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):598-606. PubMed ID: 31058289
[TBL] [Abstract][Full Text] [Related]
19. Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
